(19)
(11) EP 3 899 040 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.06.2025 Bulletin 2025/24

(45) Mention of the grant of the patent:
30.04.2025 Bulletin 2025/18

(21) Application number: 19820697.1

(22) Date of filing: 09.12.2019
(51) International Patent Classification (IPC): 
C12Q 1/6869(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6869
 
C-Sets:
C12Q 1/6869, C12Q 2525/186, C12Q 2527/125, C12Q 2527/127;
(86) International application number:
PCT/EP2019/084166
(87) International publication number:
WO 2020/126593 (25.06.2020 Gazette 2020/26)

(54)

METHOD OF POLYNUCLEOTIDE SEQUENCING

VERFAHREN ZUR POLYNUKLEOTIDSEQUENZIERUNG

PROCÉDÉ DE SÉQUENÇAGE DE POLYNUCLÉOTIDES

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 17.12.2018 US 201862780746 P

(43) Date of publication of application:
27.10.2021 Bulletin 2021/43

(73) Proprietor: Illumina Cambridge Limited
Cambridge CB21 6DF (GB)

(72) Inventors:
  • GATTI-LAFRANCONI, Pietro
    Cambridge, Cambridgeshire CB21 6DF (GB)
  • SANSOM, Helen
    Cambridge, Cambridgeshire CB21 6DF (GB)
  • HANCOCK, Matthew
    Cambridge, Cambridgeshire CB21 6DF (GB)

(74) Representative: Murgitroyd & Company 
165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)


(56) References cited: : 
US-A1- 2018 127 809
US-B2- 10 036 011
US-B2- 9 765 384
 US-A1- 2018 148 781
US-B2- 9 217 178
   
  • BIEWENGA G P ET AL: "THE PHARMACOLOGY OF THE ANTIOXIDANT LIPOIC ACID", GENERAL PHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 29, no. 3, 1997, pages 315 - 331, XP001096077, ISSN: 0306-3623, DOI: 10.1016/S0306-3623(96)00474-0
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).